Enhancement of antigen-specific immunity via the TLR4 ligands MPL™ adjuvant and Ribi.529
- Jay T. Evans
- , Christopher W. Cluff
- , David A. Johnson
- , Michael J. Lacy
- , David H. Persing
- , Jory R. Baldridge
- GlaxoSmithKline
Research output: Contribution to journal › Review article › peer-review
229
Scopus
citations